AUSTIN, Texas--(BUSINESS WIRE)--Introgen Therapeutics, Inc. (NASDAQ:INGN) announced today its financial results for the second quarter ended June 30, 2007. Additional operational and financial details will be reported in the Company’s quarterly report on Form 10-Q to be filed with the Securities and Exchange Commission. The Company reports that financial and operational results are consistent with its expectations.
